NO20011911L - Fluticasonv¶ske med forbedret vasokonstriktor aktivitet - Google Patents

Fluticasonv¶ske med forbedret vasokonstriktor aktivitet

Info

Publication number
NO20011911L
NO20011911L NO20011911A NO20011911A NO20011911L NO 20011911 L NO20011911 L NO 20011911L NO 20011911 A NO20011911 A NO 20011911A NO 20011911 A NO20011911 A NO 20011911A NO 20011911 L NO20011911 L NO 20011911L
Authority
NO
Norway
Prior art keywords
fluticasone
fluid
enhanced
vasoconstrictor activity
vasoconstrictor
Prior art date
Application number
NO20011911A
Other languages
English (en)
Other versions
NO20011911D0 (no
Inventor
Gordon J Dow
Keith Arthur Johnson
Frances Furr Kelly
Robert William Lathrop
Rukmini Rajagopalan
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10841015&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20011911(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20011911L publication Critical patent/NO20011911L/no
Publication of NO20011911D0 publication Critical patent/NO20011911D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Flutikasonvæske med forbedret vasokonstriktor og anti-inflammatorisk aktivitet og høyere enn ventet potens er beskrevet. Flutikasonvæsken inneholder 0,05 vekt-% flutikason propionat og en olje-i-vann bærer som innbefatter eksipienter. Flutikasonvæsken er uventet effektiv med en forbedret trygghetsprofil.
NO20011911A 1998-10-22 2001-04-18 Fluticasonv¶ske med forbedret vasokonstriktor aktivitet NO20011911D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9823036.0A GB9823036D0 (en) 1998-10-22 1998-10-22 Fluticasone lotion having improved vasoconstrictor activity
PCT/GB1999/003472 WO2000024401A1 (en) 1998-10-22 1999-10-20 Fluticasone lotion having improved vasoconstrictor activity

Publications (2)

Publication Number Publication Date
NO20011911L true NO20011911L (no) 2001-04-18
NO20011911D0 NO20011911D0 (no) 2001-04-18

Family

ID=10841015

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011911A NO20011911D0 (no) 1998-10-22 2001-04-18 Fluticasonv¶ske med forbedret vasokonstriktor aktivitet

Country Status (18)

Country Link
US (1) US7300669B2 (no)
EP (1) EP1123101A1 (no)
JP (1) JP2002528418A (no)
KR (1) KR20010073220A (no)
CN (1) CN1176659C (no)
AU (1) AU754480B2 (no)
BR (1) BR9914703A (no)
CA (1) CA2347109A1 (no)
CZ (1) CZ20011419A3 (no)
GB (1) GB9823036D0 (no)
HU (1) HUP0104251A2 (no)
IL (1) IL142471A0 (no)
NO (1) NO20011911D0 (no)
NZ (1) NZ510949A (no)
PL (1) PL348029A1 (no)
TR (1) TR200101109T2 (no)
WO (1) WO2000024401A1 (no)
ZA (1) ZA200102971B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR032362A1 (es) * 2000-08-14 2003-11-05 Glaxo Group Ltd Formulacion topica estable de una emulsion de aceite en agua y proceso para su preparacion
US7897587B2 (en) 2004-09-03 2011-03-01 Nycomed Us Inc. Topical dermatological formulations and use thereof
US20090233891A1 (en) * 2008-03-11 2009-09-17 Glenmark Generics Ltd. Pharmaceutical lotion comprising fluticasone propionate
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US20140371179A1 (en) * 2013-06-13 2014-12-18 Professional Compounding Centers Of America Methods and Compositions for Treating Esophageal Diseases
WO2016205001A1 (en) 2015-06-18 2016-12-22 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis
US10653656B2 (en) 2018-04-05 2020-05-19 Bausch Health Ireland Limited Topical pharmaceutical compositions for treating skin conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning
GB8630913D0 (en) * 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
GB9103764D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Compositions
WO1994014472A1 (en) * 1992-12-22 1994-07-07 The Regents Of The University Of California Method for inhibition of cell adhesion to receptors containing selectins

Also Published As

Publication number Publication date
AU754480B2 (en) 2002-11-14
PL348029A1 (en) 2002-05-06
IL142471A0 (en) 2002-03-10
CZ20011419A3 (cs) 2001-09-12
US7300669B2 (en) 2007-11-27
BR9914703A (pt) 2001-07-10
CN1176659C (zh) 2004-11-24
GB9823036D0 (en) 1998-12-16
AU6352499A (en) 2000-05-15
CN1326350A (zh) 2001-12-12
NO20011911D0 (no) 2001-04-18
HUP0104251A2 (hu) 2002-04-29
TR200101109T2 (tr) 2001-09-21
ZA200102971B (en) 2002-06-26
CA2347109A1 (en) 2000-05-04
JP2002528418A (ja) 2002-09-03
EP1123101A1 (en) 2001-08-16
US20040176342A1 (en) 2004-09-09
WO2000024401A1 (en) 2000-05-04
NZ510949A (en) 2003-11-28
KR20010073220A (ko) 2001-07-31

Similar Documents

Publication Publication Date Title
ES2195970T3 (es) L-ribavirina y usos de la misma.
ES2124373T3 (es) Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico.
PT1109812E (pt) Pirrolobenzodiazepinas
HUP9701560A1 (hu) "Olaj a vízben"típusú topikális alkalmazású folyékony emulzió készítmény
ES2175127T3 (es) Derivados de la quinazolina y su uso.
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
NO963370D0 (no) Nye mercaptoacetylamido-1,3,4,5-tetrahydro-benzo[cÅazepin-3-on-disulfidderivater som er anvendbare som inhibitorer av enkefalinase og ACE
IT1285770B1 (it) Composti corticoidei
SV1994000083A (es) Derivados de indol, su preparacion y uso, ref. 1215ml/sv.
NO20011911L (no) Fluticasonv¶ske med forbedret vasokonstriktor aktivitet
EA200200545A1 (ru) Онколитические комбинации для лечения рака
ES2133412T3 (es) 2',5'-oligoadenilato-2',3'-ciclofosfatos y 2',5'-oligoadenilatos con actividad sobre el virus papiloma.
NO20011583D0 (no) 2-methyl-thieno-benzodiazepine formulering
GB2380939B (en) Treatment or prevention of auto-immune diseases
DK1041869T3 (da) På anvendelsesstedet udformet EMI pakning
BR9812780A (pt) 2-aril-3-aroilbenzo[b]tiofenos úteis para o tratamento de sìndrome da perda de estrogênio
DE69727583D1 (de) Vermeidung von gastrointestinaler schädigung
ATE253923T1 (de) Verhütung von magen-darm schäden
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
GR3036508T3 (en) 4-[(thien-2-yl)methyl]imidazole derivatives having alpha2-adrenoceptor agonistic activity
ES2135535T3 (es) Derivados tiazolotriazol y tiazolodiazol con actividad fungicida.
BR9307644A (pt) Exaustor, e unidade de turbina d'água e exaustor combinados
ES2141948T3 (es) Derivados de ciclohexanona, procedimiento para su preparacion y productos intermedios del procedimiento.
ES2136965T3 (es) Derivados de 17-hidroxiiminoalquil y 17-hidroxiiminometilalquenil ciclopentanperhidrofenantreno activos sobre el sistema cardiovascular un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ATE243695T1 (de) 5-bicycloindolverbindungen